Stadmed Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.29 M
- Company Age 73 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.81 Cr
- Revenue Growth 6.09%
- Profit Growth -22.59%
- Ebitda -27.83%
- Net Worth 17.28%
- Total Assets 10.51%
About Stadmed
Stadmed Pvt Ltd (SPL) was founded in India on 22 June 1951 and has a glorious history of 73 years and seven months. Its registered office is in Kolkata, West Bengal, India.
The Corporate was formerly known as Standard Medical Research Institute Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.29 M.
The company currently has active open charges totaling ₹14.81 Cr.
Ashish Roy, Amit Ray, Anjan Roy, and One other member serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24234WB1951PTC012791
-
Company No.
012791
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jun 1951
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
What products or services does Stadmed Pvt Ltd offer?
Stadmed Pvt Ltd offers a wide range of products and services, including Antihistamines, Cetirizine Tablet, Antipyretic Medication, Paracetamol Suspension, Pharmaceutical Syrup, Oral Suspension, Paracetamol Tablets, Antacid Drugs, Gelusil Syrup, Pharmaceutical Tablets.
Who are the key members and board of directors at Stadmed?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Roy
|
Director | 19-Mar-1976 | Current |
|
Amit Ray
|
Director | 17-Feb-1979 | Current |
|
Anjan Roy
|
Whole-Time Director | 19-Mar-1976 | Current |
|
Sushil Roy
|
Director | 13-Mar-1959 | Current |
Financial Performance of Stadmed.
Stadmed Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 6.09% increase. The company also saw a substantial fall in profitability, with a 22.59% decrease in profit. The company's net worth Soared by an impressive increase of 17.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stadmed?
In 2023, Stadmed had a promoter holding of 72.31% and a public holding of 27.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Synar Trading Private LimitedAshish Roy is a mutual person
Charges (Loans)
₹148.10 M
₹0
Charges Breakdown by Lending Institutions
- Others : 14.81 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jul 1988 | Others | ₹14.81 Cr | Open |
How Many Employees Work at Stadmed?
Stadmed has a workforce of 599 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stadmed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stadmed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
